Structure-activity relationship of flavonoids for inhibition of epidermal growth factor-induced transformation of JB6 Cl 41 cells.
- Published in:
- Molecular Carcinogenesis, 2007, v. 46, n. 6, p. 436, doi. 10.1002/mc.20292
- By:
- Publication type:
- Article
Works matching IS 08991987 AND DT 2007 AND VI 46 AND IP 6
Results: 7
1
2
Potentiation of chemotherapeutics by the Hsp90 antagonist geldanamycin requires a steady serum condition.
- Published in:
- Molecular Carcinogenesis, 2007, v. 46, n. 6, p. 466, doi. 10.1002/mc.20296
- By:
- Publication type:
- Article
3
The twenty-first Aspen Cancer Conference: Mechanisms of toxicity, carcinogenesis, cancer prevention, and cancer therapy, 2006.
- Published in:
- Molecular Carcinogenesis, 2007, v. 46, n. 6, p. 415, doi. 10.1002/mc.20291
- By:
- Publication type:
- Article
4
Mouse skin chemical carcinogenesis is inhibited by antizyme in promotion-sensitive and promotion-resistant genetic backgrounds.
- Published in:
- Molecular Carcinogenesis, 2007, v. 46, n. 6, p. 453, doi. 10.1002/mc.20294
- By:
- Publication type:
- Article
5
Epidermal hyperplasia and oral carcinoma in mice overexpressing the transcription factor ATF3 in basal epithelial cells.
- Published in:
- Molecular Carcinogenesis, 2007, v. 46, n. 6, p. 476, doi. 10.1002/mc.20298
- By:
- Publication type:
- Article
6
MMP-7 (matrilysin) expression in human brain tumors.
- Published in:
- Molecular Carcinogenesis, 2007, v. 46, n. 6, p. 446, doi. 10.1002/mc.20293
- By:
- Publication type:
- Article
7
A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.
- Published in:
- Molecular Carcinogenesis, 2007, v. 46, n. 6, p. 488, doi. 10.1002/mc.20297
- By:
- Publication type:
- Article